Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Private prescription"'
Publikováno v:
American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 187:549-560
We previously reported increased pain and gastrointestinal (GI) medication prescription claims among persons with Ehlers-Danlos syndromes (EDS) and peripubertal increase in opioid and anti-emetic claims among women with EDS. Herein, we hypothesized a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539abeb637b010e99ffee5c9f2c71350
https://doi.org/10.1002/ajmg.c.31947
https://doi.org/10.1002/ajmg.c.31947
Autor:
Amanda Starc, Ashley Swanson
Publikováno v:
American Economic Journal: Economic Policy. 13:406-446
Selective contracting is an increasingly popular tool for reducing health care costs, but any savings must be weighed against consumer surplus losses from restricted access. Recently, many prescription drug plans (PDPs) utilize preferred pharmacy net
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a12f24b2e905d6e19f4eab036484e7e4
https://doi.org/10.1257/pol.20180489
https://doi.org/10.1257/pol.20180489
Publikováno v:
Arthritis careresearchREFERENCES.
OBJECTIVE Joint hypermobility in Ehlers-Danlos Syndromes (EDS) predisposes persons with EDS to frequent subluxations and dislocations, chronic arthralgia, and soft-tissue rheumatism. Epidemiological trends of rheumatologic conditions among persons wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace481e672e7658a4a7733fbba1e454c
https://pubmed.ncbi.nlm.nih.gov/34788905
https://pubmed.ncbi.nlm.nih.gov/34788905
Autor:
Emma Anderson, Hayley Berry
Publikováno v:
BMJ Sexual & Reproductive Health. 47:1-3
The article by Turnbull et al 1 reports that pharmacies are important in the choice of settings from which emergency hormonal contraception (EHC) can be obtained. This article outlines the postgraduate education that is provided to pharmacy professio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba0693790bca0636b495d6de1abdc1f
https://doi.org/10.1136/bmjsrh-2020-200645
https://doi.org/10.1136/bmjsrh-2020-200645
Autor:
Katy Roy, Vincent J Cornelisse, Andrew E. Grulich, Edwina J. Wright, Bill Whittaker, Darryl O'Donnell, Levinia Crooks, Mark A. Boyd, Iryna Zablotska, Darren Russell
Publikováno v:
Journal of Virus Eradication
Journal of Virus Eradication, Vol 3, Iss 3, Pp 168-184 (2017)
Journal of Virus Eradication, Vol 3, Iss 3, Pp 168-184 (2017)
Daily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be1c750142cb96874e837a0fb6dea06
http://europepmc.org/articles/PMC5518248
http://europepmc.org/articles/PMC5518248
Autor:
Michael R. Law, Talshyn Bolatova
Publikováno v:
CMAJ open. 7(4)
Background Canada does not have universal public coverage for prescription drugs, which leaves an important role for private insurance plans. However, we do not have recent data on the characteristics of Canadians who report holding such coverage, pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee4f9b2d2c35f7371660a93007a96dd
https://pubmed.ncbi.nlm.nih.gov/31604712
https://pubmed.ncbi.nlm.nih.gov/31604712
Autor:
Klaus Jansen, Ulrich Marcus, Stefan Albrecht, Barbara Gunsenheimer-Bartmeyer, Uwe Koppe, Viviane Bremer, Heiko Jessen
Publikováno v:
Journal of the International AIDS Society
Introduction Until September 2019, pre‐exposure prophylaxis (PrEP) with tenofovir disoproxil/emtricitabine for HIV prevention was not covered by health insurance plans in Germany, and was only available through private prescriptions with self‐pay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91f674e3f92d374550c647f81c339fb
https://doi.org/10.1002/jia2.25395
https://doi.org/10.1002/jia2.25395
Autor:
Julie C. Lauffenburger, Nina Jain, Aaron S. Kesselheim, Kerstin Noëlle Vokinger, Thomas J Hwang
Publikováno v:
JAMA internal medicine. 179(3)
Importance The US Department of Health and Human Services (HHS) has proposed to reform drug pricing in Medicare Part B, which primarily covers physician-administered drugs and biologic agents. One HHS proposal would shift coverage of certain drugs fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d165783f8d3753c132146be4f7cb7f03
https://pubmed.ncbi.nlm.nih.gov/30640365
https://pubmed.ncbi.nlm.nih.gov/30640365
Autor:
Nicole R. Greenspan, Zack Marshall, Shelley Marshall, Chris Kaposy, Cynthia Kitson, Jill Allison
Publikováno v:
Healthcare Management Forum. 29:255-259
Antiretroviral therapy for HIV can be expensive if paid for out of pocket. In Canada, there are a variety of federal, provincial, and private prescription drug plans that lower the cost of these lifesaving medications for people living with HIV, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ea3dbde172b3583f0188a0d55f6abf
https://doi.org/10.1177/0840470416660569
https://doi.org/10.1177/0840470416660569
Autor:
Andrew E. Grulich, Vincent J Cornelisse, Darren Russell, Mark A. Boyd, Iryna Zablotska, Darryl O'Donnell, Katy Roy, Edwina J. Wright, Bill Whittaker, Levinia Crooks
Publikováno v:
Journal of Virus Eradication, Vol 4, Iss 3, Pp 143-159 (2018)
Journal of Virus Eradication
Journal of Virus Eradication
Daily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4a15d69bd5ce4b7595dcf199ab64ba
https://pubmed.ncbi.nlm.nih.gov/30050676
https://pubmed.ncbi.nlm.nih.gov/30050676